Tryptic peptide mapping of fibronectin from various species indicates that (i) there exists a remarkable similarity between methionine-labeled tryptic peptides of fibronectins isolated from cells of widely separated species such as human, chicken, mouse, hamster, and rat; (ii) fibronectins from normal and transformed or tumor cells of the same species are very similar, if not identical; and (iii) collagen-binding regions of fibronectin from different species share identical major peptides.
Fibronectin, a major surface glycoprotein of various cell types, is involved in some of the basic cellular functions such as adhesion and migration (1) (2) (3) (4) (5) (6) . It is, therefore, not surprising that fibronectins isolated from different species seem to be structurally related based upon analysis by limited proteolysis (7, 8) . Studies in many laboratories have revealed that multiple specific binding sites exist on the fibronectin molecule that are responsible for its interaction with a number of macromolecules and with the cell surface (reviewed in refs. [1] [2] [3] [4] [5] [6] . The interactions of fibronectin with collagen and glycosaminoglycans appear to be involved in the formation of extracellular matrices (9) (10) (11) (12) (13) (14) (15) (16) (17) . In particular, the collagenbinding domain offibronectin has been a subject of intensive studies, as fibronectin seems to mediate the attachment of several cell types to collagen (18) (19) (20) . Moreover, it recently has been reported that a transformation-enhancing activity present in the sera of tumor patients is related to collagenbinding fragments of fibronectin (21) .
This investigation represents a comparative study offibronectin molecules and their collagen-binding fragments from several different cell lines by two-dimensional tryptic peptide analysis. The results demonstrate a close structural similarity between fibronectins, especially their collagenbinding fragments, obtained from widely separated species, indicating that fibronectin has been highly conserved in evolution.
MATERIALS AND METHODS
Cell Cultures and Radioactive Labeling. The human fibroblast line GM-0077, obtained from the Institute for Medical Research (Camden, NJ), and the human bladder carcinoma line HT-1376, obtained from S. Rasheed (University of Southern California), were cultured in Dulbecco's modified Eagle's medium (DME medium) with 10% fetal calf serum. Normal rat kidney cells (NRK cells), the transformed derivative BH-RSV-NRK, tertiary chicken embryo fibroblasts (CEF), and DBA, a cell line derived from mouse embryo cells, were all grown in DME medium with 10% fetal calf serum. The hamster fibroblast line NIL 8 and its transformed counterpart NIL-8-HSV were grown in DME medium with 5% fetal calf serum.
For radioactive labeling with [35S]methionine (250 uCi/ml; New England Nuclear, 500 Ci/mmol; 1 Ci = 37 GBq), the concentration of methionine in the medium was reduced to 1/10th of the normal amount. Cells were labeled for 24 hr.
Purification of Fibronectin and Collagen-Binding Domain of Fibronectin, Fibronectin was purified by immunoprecipitation of the labeled conditioned media from all cell lines by using anti-hamster fibronectin antiserum as described (7) . For isolation of the collagen-binding domain of fibronectin, the labeled conditioned medium was agitated with gelatin (denatured type I collagen from pig skin)-Sepharose beads (22) for 30 min at 40C. After centrifugation the supernatant was removed, and the beads were washed several times with phosphate-buffered saline and finally resuspended in phosphate-buffered saline. The fibronectin bound to the gelatinSepharose beads was digested with chymotrypsin (10 ttg/ml) for 15 min at room temperature (23) . The reaction was stopped by adding 5 mM phenylmethysulfonyl fluoride and 2 mg of soybean trypsin inhibitor per ml. The beads were then packed in a small column and washed with phosphate-buffered saline, and the fragments of fibronectin bound to the gelatin-Sepharose beads were eluted with 4 M urea. The peak fractions were analyzed on a 10% polyacrylamide gel by using the Laemmli buffer system (24) .
Tryptic Peptide Mapping. Bands of [35S]methionine-labeled fibronectins and the collagen-binding fragments of fibronectins were excised from dried preparative gels. The proteins were recovered from hydrated gels by the method of Beemon and Hunter (25) . Tryptic peptide mapping was done exactly as described earlier (7).
RESULTS
Two-Dimensional Tryptic Peptide Analysis of Fibronectins.
Purified [35S]methionine-labeled fibronectins from normal
and transformed or tumor cells of various species, including chicken, mouse, human, rat, and hamster, were subjected to exhaustive trypsin digestion followed by two-dimensional separation on thin-layer cellulose plates. The fluorographs of the tryptic peptide maps are shown in Fig. 1 . The maps of all the cell lines appeared to be strikingly similar. At least 13 major tryptic peptides with identical relative mobilities were detected in the fibronectins from all normal and transformed or tumor cell lines. The complexity of the maps makes it diffcult to identify other major or minor peptides shared by the fibronectins from all cell lines. Peptide 14 was absept in the map of CEF ( 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" (1984) 0077 and NRK cells (Fig. 1 c and f) were unique to these cell lines. Peptide 1 from the fibronectins of CEF and human fibroblasts GM-0077 and HT-1376 had slower mobility in the second dimension (Fig. 1 a, (Fig. 1 g   and h) . The distributions of the peptides in the maps of fibronectins from fibroblast line GM-0077 versus a bladder carcinoma line HT-1376 and from normal hamster and rat cells versus their viral transformants were identical (Fig. 1, compare  c with d, e with f, and g with h) . No significant difference was detected between the fibronectins from normal and transformed hamster cells (Fig. 1 g and h) . The amount of some of the minor peptides varied in the maps offibronectins from normal versus tumor or transformed cells in the case of human and NRK cells (Fig. 1 , compare c with d and e with f). It is not known whether the variation in the intensity of some of the peptides was artifactual or due to the microheterogeneity in the fibronectin molecules.
Isolation of Collagen-Binding Fragment of Fibronectin. Chymotryptic digestion of fibronectin from NIL-8 cells gave rise to a major gelatin-binding fragment of Mr 40,000 (Fig. 2,  lane B) . In the case of fibronectin from GM-0077 fibroblasts, in addition to a major Mr 40,000 fragment, another fragment of Mr 50,000 and a diffuse fragment with mobility around Mr 20,000 also remained bound to gelatin (Fig. 2, lane C) . Under the conditions used, treatment offibronectin from NRK cells with chymotrypsin generated two gelatin-binding fragments of Mrs around 50,000 and 45,000 (Fig. 2, lane D 2) were isolated by preparative gel electrophoresis. These peptides were then eluted from the gels and subjected to extensive trypsin digestion, followed by two-dimensional analysis of the digests. The collagen-binding domains of fibronectins from all three cell lines-i.e., GM-0077, NIL-8, and NRK-had similar tryptic peptide maps (Fig. 3) . The spots were numbered according to their relative positions in the maps of intact fibronectins. Peptide 1, which had a slower mobility in the proteins from CEF and human fibroblasts, was present in the collagen-binding domain, and so were peptides 3, 4, 5, and 10. The positions of another major peptide marked as A in all three maps of Fig. 3 and of the two relatively minor peptides (marked by arrows in Fig. 3 a and b and not visible in the photograph of Fig. 3c because of lowlevel radioactivity) could not be determined in the maps of intact fibronectins. They probably represent new peptides produced by the digestion of fibronectin with chymotrypa A4 . The maps of the collagen-binding fragments of Mr 50,000 present in the fibronectins from NRK and GM-0077 cells (Fig. 2, lanes C and D) were identical to the ones shown in Fig. 3 a and c , with a few additional minor spots (data not shown).
DISCUSSION
The comparison of fibronectins from several normal and transformed or tumor cell lines by two-dimensional tryptic peptide analysis shows a remarkable structural similarity. Especially the tryptic maps of fibronectins from a human fibroblast line GM-0077 and a bladder carcinoma line HT-1376 and fibronectins from hamster and rat cell lines and their virally transformed counterparts are essentially the same. This is in agreement with the observation that there is no significant structural difference between the fibronectins from human fibroblast lines and two tumor lines, a fibrosarcoma and a rhabdomyosarcoma (unpublished data). Also, most of the major tryptic peptides of [35S]methionine-labeled fibronectins are shared by widely diverged species such as human, chicken, mouse, hamster, and rat. However, there are some spots that are unique to a particular cell line and some spots that are shared by some but not all cell lines.
The tryptic peptide maps of the collagen-binding fragment of fibronectin from different cell lines are shown in Fig. 3 . There seems to be an enrichment of methionine-containing peptides in this region. Of roughly 15 major peptides found in the maps of intact fibronectin, 6 are present in the Mr 40,000-45,000 fragments that bind to collagen (compare Fig.  3 with Fig. 1 ). This is consistent with the observation that most of the methionine residues of plasma fibronectin are present in the Mr 72,000 collagen-binding peptide (26) . Furthermore, the tryptic peptides of the collagen-binding domain are strikingly similar in fibronectins from all three cell lines examined here-i.e., NRK, NIL-8 hamster cells, and human skin fibroblasts GM-0077. This suggests strongly the relatedness of the collagen-binding region of fibronectins in different species and is consistent with the observation that the collagen-binding fragment of fibronectin is poorly immunogenic (27) . This also would be in agreement with the conserved nature of collagens, in particular with the highly conservative structure of the sequences in collagen that interact with fibronectin and also contain the cleavage site for collagenase (28) (29) (30) .
Although the distribution of tryptic peptides of fibronectins from various species indicates a strong similarity of structure in general and of the collagen binding fragments in particular, it does not provide an entirely rigorous basis for such relatedness in the overall structure for two reasons. (i) The fibronectins were labeled with [35S]methionine, which is probably one of the rather infrequent amino acids present in proteins of both prokaryotic and eukaryotic origin (31, 32) . Analysis of the amino acid composition of both cellular and plasma fibronectin has shown about 1-2 mol % of methionine residues (32) (33) (34) (35) . Therefore, the map of methionine-labeled fibronectin represents probably about 10% of the molecule. (ii) The cleavage sites of only one enzyme, trypsin, were studied in this investigation, demonstrating a high degree of conservation of trypsin-sensitive sites and methionine-containing peptides in fibronectin. It is conceivable that other proteases or labeling with other amino acids might reveal more of the structural differences in fibronectins from different species.
Fibronectin has a complex molecular structure and is composed of discrete functional and structural domains. Amino acid sequence analysis has shown that several regions of internal homology occur in bovine plasma fibronectin (36) . A recent study at the genomic level also has revealed a regular structural organization of the fibronectin gene from chicken cells (37) . A detailed structural analysis offibronectin and its various specific domains, using approaches at both the genomic and protein levels, should soon provide a better insight of its role in a variety of cellular functions of a diverse nature.
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